The Randstad, Netherlands
I work in public health microbiology at the Dutch National Institute for Public Health and the Environment (RIVM) for many years. My present work focuses on antimicrobial resistance and health care associated infections, with a focus on carbapenemases and MRSA. After obtaining a PhD on the virological and immunological effects of HIV combination therapy in 2000 and medical specialization as a medical microbiologist, I started working at the RIVM in 2005. Over the years, I have worked on various bacterial pathogens with public health relevance, such as Salmonella, Clostridium difficile, Bordetella pertussis (whooping cough), Coxiella burnetii (Q fever), Borrelia burgdorferi (Lyme borreliose), Shiga toxin producing E. coli (STEC), carbapenemase producing Enterobacterales and Francisella tularensis. I have (co-)authored over 130 PubMed enlisted publications (for a selection of titles, see below).
Public health microbiology, bacteriology, infectious disease outbreak control, research. Topics: antimicrobial resistance and health care associated infections, Clostridium difficile infections, Lyme borreliosis, Francisella tularensis, pertussis, Salmonella outbreaks, Q fever, high-impact bacterial pathogens.
Clinical microbiology Next to my RIVM work
Physician-researcher at National AIDS Therapy Evaluation Center (NATEC), Academic Medical Center (AMC), Amsterdam, The Netherlands for several phase II en III trials with antiretroviral drugs. PhD project. Thesis: The 'Triple Study'. Viral dynamics and immune reconstitution in HIV-1 infection during potent antiretroviral therapy.